10 research outputs found
ΠΠΏΡΠ°ΠΌΠ΅ΡΡ Π΄Π»Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ Π³Π»ΠΈΠ°Π»ΡΠ½ΡΡ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
Purpose of the study: to evaluate the feasibility of using functional analogues of protein antibodies β dNa/ RNa aptamers in diagnostics, treatment and prognosis of human brain glial tumors.Material and Methods. The relevant literature sources were searched in scopus, Web of science, pubmed, elibrary with inclusion of publications from 2000 to 2023. sixty articles are presented in the review.Results. The analysis of the literature devoted to classification, diagnostics and therapy of brain glioblastomas was carried out and the feasibility of using for in vivo diagnostics and therapy of this disease aptamers, which are molecular recognition elements based on DNA/RNA oligonucleotides, capable of binding to the given molecular targets and distinguishing even separate functional groups in them, was studied. A list of aptamers to human glial brain tumors and their molecular targets that can be used for diagnostics and therapy of glioblastoma, including tumor imaging by pet/ct, mRi, plasmon resonance, fluorescence and confocal microscopy, etc., is presented. literature data suggest that DNA/RNA aptamers can be used to search for circulating tumor cells in the blood of glioblastoma patients, to target therapeutic drugs to the tumor and to inhibit tumor growth.Conclusion. Brain glioblastoma is a heterogeneous tumor consisting of cells at different stages of malignancy and, accordingly, with a different set of oncogenes. For this reason, a multitarget strategy that includes combined suppression of angiogenesis, invasion, metastasis, proliferation and survival of tumor cells should be proposed for the therapy of this disease. DNA/RNA aptamers tailored to key proteins involved in oncogenic transformation may be suitable candidates for the implementation of multitarget therapy for brain glioblastoma.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΡΠ΅Π½ΠΈΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π°Π½Π°Π»ΠΎΠ³ΠΎΠ² Π±Π΅Π»ΠΊΠΎΠ²ΡΡ
Π°Π½ΡΠΈΡΠ΅Π» β ΠΠΠ/Π ΠΠ-Π°ΠΏΡΠ°ΠΌΠ΅ΡΠΎΠ² Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅, Π»Π΅ΡΠ΅Π½ΠΈΠΈ ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π³Π»ΠΈΠ°Π»ΡΠ½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΎΠΈΡΠΊ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΡΡΠΈΡ
ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΎΠ² Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π² ΡΠΈΡΡΠ΅ΠΌΠ°Ρ
scopus, Web of science, pubmed, elibrary Ρ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΉ Ρ 2000 ΠΏΠΎ 2023 Π³. Π ΠΎΠ±Π·ΠΎΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΈΠ· 60 ΡΡΠ°ΡΠ΅ΠΉ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ, ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΠΎΠΉ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ, Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π³Π»ΠΈΠΎΠ±Π»Π°ΡΡΠΎΠΌ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π΄Π»Ρ in vivo Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΡΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π°ΠΏΡΠ°ΠΌΠ΅ΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΡΡ ΡΠΎΠ±ΠΎΠΉ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠ΅ ΡΠ°ΡΠΏΠΎΠ·Π½Π°ΡΡΠΈΠ΅ ΡΠ»Π΅ΠΌΠ΅Π½ΡΡ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΠΠ/Π ΠΠ-ΠΎΠ»ΠΈΠ³ΠΎΠ½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄ΠΎΠ², ΡΠΏΠΎΡΠΎΠ±Π½ΡΡ
ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΡΡ Ρ Π·Π°Π΄Π°Π½Π½ΡΠΌΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΌΠΈ ΠΌΠΈΡΠ΅Π½ΡΠΌΠΈ ΠΈ ΡΠ°Π·Π»ΠΈΡΠ°ΡΡ Π² Π½ΠΈΡ
Π΄Π°ΠΆΠ΅ ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ Π³ΡΡΠΏΠΏΡ. ΠΡΠΈΠ²Π΅Π΄Π΅Π½ ΡΠΏΠΈΡΠΎΠΊ ΠΈΠ· Π°ΠΏΡΠ°ΠΌΠ΅ΡΠΎΠ² ΠΊ Π³Π»ΠΈΠ°Π»ΡΠ½ΡΠΌ ΠΎΠΏΡΡ
ΠΎΠ»ΡΠΌ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΈ ΠΈΡ
ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ
ΠΌΠΈΡΠ΅Π½Π΅ΠΉ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΌΠΎΠ³ΡΡ Π±ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Ρ Π΄Π»Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π³Π»ΠΈΠΎΠ±Π»Π°ΡΡΠΎΠΌΡ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π΄Π»Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ ΠΠΠ’/ΠΠ’, ΠΠ Π’, ΠΏΠ»Π°Π·ΠΌΠΎΠ½Π½ΠΎΠ³ΠΎ ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ°, ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠ½ΠΎΠΉ ΠΈ ΠΊΠΎΠ½ΡΠΎΠΊΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΠΈ ΠΈ Π΄Ρ. ΠΠ°Π½Π½ΡΠ΅ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ ΡΠΎΠΌ, ΡΡΠΎ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΠΠ/Π ΠΠ-Π°ΠΏΡΠ°ΠΌΠ΅ΡΠΎΠ² ΠΌΠΎΠΆΠ½ΠΎ ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΡΡ ΠΏΠΎΠΈΡΠΊ ΡΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠΈΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ Π² ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π³Π»ΠΈΠΎΠ±Π»Π°ΡΡΠΎΠΌΠΎΠΉ, Π°Π΄ΡΠ΅ΡΠ½ΡΡ Π΄ΠΎΡΡΠ°Π²ΠΊΡ ΠΊ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΈ ΠΏΠΎΠ΄Π°Π²Π»ΡΡΡ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠΉ ΡΠΎΡΡ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ»ΠΈΠΎΠ±Π»Π°ΡΡΠΎΠΌΠ° Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° β Π³Π΅ΡΠ΅ΡΠΎΠ³Π΅Π½Π½Π°Ρ ΠΎΠΏΡΡ
ΠΎΠ»Ρ, ΡΠΎΡΡΠΎΡΡΠ°Ρ ΠΈΠ· ΠΊΠ»Π΅ΡΠΎΠΊ, Π½Π°Ρ
ΠΎΠ΄ΡΡΠΈΡ
ΡΡ Π½Π° ΡΠ°Π·Π½ΠΎΠΉ ΡΡΠ°Π΄ΠΈΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ ΠΈ, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ, Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌ Π½Π°Π±ΠΎΡΠΎΠΌ ΠΎΠ½ΠΊΠΎΠ³Π΅Π½ΠΎΠ². ΠΠΌΠ΅Π½Π½ΠΎ ΠΏΠΎΡΡΠΎΠΌΡ Π΄Π»Ρ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΡΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π΄ΠΎΠ»ΠΆΠ½Π° Π±ΡΡΡ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π° ΠΌΡΠ»ΡΡΠΈΡΠ°ΡΠ³Π΅ΡΠ½Π°Ρ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡ, ΠΊΠΎΡΠΎΡΠ°Ρ Π²ΠΊΠ»ΡΡΠ°Π΅Ρ Π² ΡΠ΅Π±Ρ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ΅ ΠΏΠΎΠ΄Π°Π²Π»Π΅Π½ΠΈΠ΅ Π°Π½Π³ΠΈΠΎΠ³Π΅Π½Π΅Π·Π°, ΠΈΠ½Π²Π°Π·ΠΈΠΈ, ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠΈ ΠΈ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ. ΠΠΎΠ΄Ρ
ΠΎΠ΄ΡΡΠΈΠΌΠΈ ΠΊΠ°Π½Π΄ΠΈΠ΄Π°ΡΠ°ΠΌΠΈ Π΄Π»Ρ ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΌΡΠ»ΡΡΠΈΡΠ°ΡΠ³Π΅ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π³Π»ΠΈΠΎΠ±Π»Π°ΡΡΠΎΠΌΡ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΌΠΎΠ³ΡΡ ΡΡΠ°ΡΡ ΠΠΠ/Π ΠΠ-Π°ΠΏΡΠ°ΠΌΠ΅ΡΡ, ΠΏΠΎΠ΄ΠΎΠ±ΡΠ°Π½Π½ΡΠ΅ ΠΊ ΠΊΠ»ΡΡΠ΅Π²ΡΠΌ Π±Π΅Π»ΠΊΠ°ΠΌ, ΡΡΠ°ΡΡΠ²ΡΡΡΠΈΠΌ Π² ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΠΈ
ENIGMAβSleep: Challenges, opportunities, and the road map
Neuroimaging and genetics studies have advanced our understanding of the neurobiology of sleep and its disorders. However, individual studies usually have limitations to identifying consistent and reproducible effects, including modest sample sizes, heterogeneous clinical characteristics and varied methodologies. These issues call for a large-scale multi-centre effort in sleep research, in order to increase the number of samples, and harmonize the methods of data collection, preprocessing and analysis using pre-registered well-established protocols. The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium provides a powerful collaborative framework for combining datasets across individual sites. Recently, we have launched the ENIGMA-Sleep working group with the collaboration of several institutes from 15 countries to perform large-scale worldwide neuroimaging and genetics studies for better understanding the neurobiology of impaired sleep quality in population-based healthy individuals, the neural consequences of sleep deprivation, pathophysiology of sleep disorders, as well as neural correlates of sleep disturbances across various neuropsychiatric disorders. In this introductory review, we describe the details of our currently available datasets and our ongoing projects in the ENIGMA-Sleep group, and discuss both the potential challenges and opportunities of a collaborative initiative in sleep medicine